Gastric Cancer Testing, Treatment and Prevention Market Report

Global and Region Gastric Cancer Testing, Treatment and Prevention Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：170
  • REPORT CODE：GMM923648
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Gastric Cancer Testing, Treatment and Prevention market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Gastric Cancer Testing, Treatment and Preventionmarket, defines the market attractiveness level of Gastric Cancer Testing, Treatment and Prevention market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Gastric Cancer Testing, Treatment and Prevention industry, describes the types of Gastric Cancer Testing, Treatment and Prevention market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gastric Cancer Testing, Treatment and Prevention market and the development prospects and opportunities of Gastric Cancer Testing, Treatment and Prevention industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gastric Cancer Testing, Treatment and Prevention market in Chapter 13.

    By Player:

    • Pfizer

    • Herceptin

    • Immunogen Merck & Company

    • Jiangsu Hengrui Medicine Co,Ltd

    • Pacific Edge Diagnostics Nz

    • Glaxosmithkline Genentech

    • Eli Lilly And Company

    • Genentech

    • Bristol Myers Squibb

    • Novartis

    • Roche

    • BMS

    • Zova Biotherapeutics

    • MSD

    • Zai Lab (Shanghai) Co, Ltd

    By Type:

    • Test

    • Treatment

    • Prevention

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Gastric Cancer Testing, Treatment and Prevention Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Gastric Cancer Testing, Treatment and Prevention Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Gastric Cancer Testing, Treatment and Prevention Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Gastric Cancer Testing, Treatment and Prevention Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Gastric Cancer Testing, Treatment and Prevention Market Analysis and Outlook to 2022

    • 7.1 Global Gastric Cancer Testing, Treatment and Prevention Consumption (2017-2022)

    • 7.2 United States Gastric Cancer Testing, Treatment and Prevention Consumption (2017-2022)

    • 7.3 Europe Gastric Cancer Testing, Treatment and Prevention Consumption (2017-2022)

    • 7.4 China Gastric Cancer Testing, Treatment and Prevention Consumption (2017-2022)

    • 7.5 Japan Gastric Cancer Testing, Treatment and Prevention Consumption (2017-2022)

    • 7.6 India Gastric Cancer Testing, Treatment and Prevention Consumption (2017-2022)

    • 7.7 South Korea Gastric Cancer Testing, Treatment and Prevention Consumption (2017-2022)

    8 Region and Country-wise Gastric Cancer Testing, Treatment and Prevention Market Analysis and Outlook to 2028

    • 8.1 Global Gastric Cancer Testing, Treatment and Prevention Consumption Forecast (2022-2028)

    • 8.2 United States Gastric Cancer Testing, Treatment and Prevention Consumption Forecast (2022-2028)

    • 8.3 Europe Gastric Cancer Testing, Treatment and Prevention Consumption Forecast (2022-2028)

    • 8.4 China Gastric Cancer Testing, Treatment and Prevention Consumption Forecast (2022-2028)

    • 8.5 Japan Gastric Cancer Testing, Treatment and Prevention Consumption Forecast (2022-2028)

    • 8.6 India Gastric Cancer Testing, Treatment and Prevention Consumption Forecast (2022-2028)

    • 8.7 South Korea Gastric Cancer Testing, Treatment and Prevention Consumption Forecast (2022-2028)

    9 Global Gastric Cancer Testing, Treatment and Prevention Market Outlook by Types and Applications to 2022

    • 9.1 Global Gastric Cancer Testing, Treatment and Prevention Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Test Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Treatment Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Prevention Consumption and Growth Rate (2017-2022)

    • 9.2 Global Gastric Cancer Testing, Treatment and Prevention Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Gastric Cancer Testing, Treatment and Prevention Market Outlook by Types and Applications to 2028

    • 10.1 Global Gastric Cancer Testing, Treatment and Prevention Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Test Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Treatment Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Prevention Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Gastric Cancer Testing, Treatment and Prevention Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Gastric Cancer Testing, Treatment and Prevention Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Gastric Cancer Testing, Treatment and Prevention Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Gastric Cancer Testing, Treatment and Prevention Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Gastric Cancer Testing, Treatment and Prevention Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Gastric Cancer Testing, Treatment and Prevention Market Competitive Analysis

    • 14.1 Pfizer

      • 14.1.1 Pfizer Company Details

      • 14.1.2 Pfizer Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Pfizer Gastric Cancer Testing, Treatment and Prevention Product and Service

    • 14.2 Herceptin

      • 14.2.1 Herceptin Company Details

      • 14.2.2 Herceptin Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Herceptin Gastric Cancer Testing, Treatment and Prevention Product and Service

    • 14.3 Immunogen Merck & Company

      • 14.3.1 Immunogen Merck & Company Company Details

      • 14.3.2 Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Product and Service

    • 14.4 Jiangsu Hengrui Medicine Co,Ltd

      • 14.4.1 Jiangsu Hengrui Medicine Co,Ltd Company Details

      • 14.4.2 Jiangsu Hengrui Medicine Co,Ltd Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Jiangsu Hengrui Medicine Co,Ltd Gastric Cancer Testing, Treatment and Prevention Product and Service

    • 14.5 Pacific Edge Diagnostics Nz

      • 14.5.1 Pacific Edge Diagnostics Nz Company Details

      • 14.5.2 Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Product and Service

    • 14.6 Glaxosmithkline Genentech

      • 14.6.1 Glaxosmithkline Genentech Company Details

      • 14.6.2 Glaxosmithkline Genentech Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Glaxosmithkline Genentech Gastric Cancer Testing, Treatment and Prevention Product and Service

    • 14.7 Eli Lilly And Company

      • 14.7.1 Eli Lilly And Company Company Details

      • 14.7.2 Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Product and Service

    • 14.8 Genentech

      • 14.8.1 Genentech Company Details

      • 14.8.2 Genentech Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Genentech Gastric Cancer Testing, Treatment and Prevention Product and Service

    • 14.9 Bristol Myers Squibb

      • 14.9.1 Bristol Myers Squibb Company Details

      • 14.9.2 Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Product and Service

    • 14.10 Novartis

      • 14.10.1 Novartis Company Details

      • 14.10.2 Novartis Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novartis Gastric Cancer Testing, Treatment and Prevention Product and Service

    • 14.11 Roche

      • 14.11.1 Roche Company Details

      • 14.11.2 Roche Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Roche Gastric Cancer Testing, Treatment and Prevention Product and Service

    • 14.12 BMS

      • 14.12.1 BMS Company Details

      • 14.12.2 BMS Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 BMS Gastric Cancer Testing, Treatment and Prevention Product and Service

    • 14.13 Zova Biotherapeutics

      • 14.13.1 Zova Biotherapeutics Company Details

      • 14.13.2 Zova Biotherapeutics Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Zova Biotherapeutics Gastric Cancer Testing, Treatment and Prevention Product and Service

    • 14.14 MSD

      • 14.14.1 MSD Company Details

      • 14.14.2 MSD Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 MSD Gastric Cancer Testing, Treatment and Prevention Product and Service

    • 14.15 Zai Lab (Shanghai) Co, Ltd

      • 14.15.1 Zai Lab (Shanghai) Co, Ltd Company Details

      • 14.15.2 Zai Lab (Shanghai) Co, Ltd Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Zai Lab (Shanghai) Co, Ltd Gastric Cancer Testing, Treatment and Prevention Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Gastric Cancer Testing, Treatment and Prevention

    • Figure Gastric Cancer Testing, Treatment and Prevention Picture

    • Table Global Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastric Cancer Testing, Treatment and Prevention Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Gastric Cancer Testing, Treatment and Prevention Consumption by Country (2017-2022)

    • Figure United States Gastric Cancer Testing, Treatment and Prevention Consumption and Growth Rate (2017-2022)

    • Table Europe Gastric Cancer Testing, Treatment and Prevention Consumption and Growth Rate (2017-2022)

    • Figure China Gastric Cancer Testing, Treatment and Prevention Consumption and Growth Rate (2017-2022)

    • Figure Japan Gastric Cancer Testing, Treatment and Prevention Consumption and Growth Rate (2017-2022)

    • Figure India Gastric Cancer Testing, Treatment and Prevention Consumption and Growth Rate (2017-2022)

    • Figure South Korea Gastric Cancer Testing, Treatment and Prevention Consumption and Growth Rate (2017-2022)

    • Figure Global Gastric Cancer Testing, Treatment and Prevention Consumption Forecast by Country (2022-2028)

    • Figure United States Gastric Cancer Testing, Treatment and Prevention Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Gastric Cancer Testing, Treatment and Prevention Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Gastric Cancer Testing, Treatment and Prevention Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Gastric Cancer Testing, Treatment and Prevention Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Gastric Cancer Testing, Treatment and Prevention Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Gastric Cancer Testing, Treatment and Prevention Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Test Consumption and Growth Rate (2017-2022)

    • Figure Global Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Prevention Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prevention Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Gastric Cancer Testing, Treatment and Prevention Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Gastric Cancer Testing, Treatment and Prevention Export by Region (Top 5 Countries) (2017-2028)

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Gastric Cancer Testing, Treatment and Prevention Product and Service

    • Table Herceptin (Foundation Year, Company Profile and etc.)

    • Table Herceptin Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

    • Table Herceptin Gastric Cancer Testing, Treatment and Prevention Product and Service

    • Table Immunogen Merck & Company (Foundation Year, Company Profile and etc.)

    • Table Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Product and Service

    • Table Jiangsu Hengrui Medicine Co,Ltd (Foundation Year, Company Profile and etc.)

    • Table Jiangsu Hengrui Medicine Co,Ltd Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangsu Hengrui Medicine Co,Ltd Gastric Cancer Testing, Treatment and Prevention Product and Service

    • Table Pacific Edge Diagnostics Nz (Foundation Year, Company Profile and etc.)

    • Table Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Product and Service

    • Table Glaxosmithkline Genentech (Foundation Year, Company Profile and etc.)

    • Table Glaxosmithkline Genentech Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glaxosmithkline Genentech Gastric Cancer Testing, Treatment and Prevention Product and Service

    • Table Eli Lilly And Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Product and Service

    • Table Genentech (Foundation Year, Company Profile and etc.)

    • Table Genentech Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Gastric Cancer Testing, Treatment and Prevention Product and Service

    • Table Bristol Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Gastric Cancer Testing, Treatment and Prevention Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Gastric Cancer Testing, Treatment and Prevention Product and Service

    • Table BMS (Foundation Year, Company Profile and etc.)

    • Table BMS Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

    • Table BMS Gastric Cancer Testing, Treatment and Prevention Product and Service

    • Table Zova Biotherapeutics (Foundation Year, Company Profile and etc.)

    • Table Zova Biotherapeutics Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zova Biotherapeutics Gastric Cancer Testing, Treatment and Prevention Product and Service

    • Table MSD (Foundation Year, Company Profile and etc.)

    • Table MSD Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

    • Table MSD Gastric Cancer Testing, Treatment and Prevention Product and Service

    • Table Zai Lab (Shanghai) Co, Ltd (Foundation Year, Company Profile and etc.)

    • Table Zai Lab (Shanghai) Co, Ltd Gastric Cancer Testing, Treatment and Prevention Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zai Lab (Shanghai) Co, Ltd Gastric Cancer Testing, Treatment and Prevention Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US